https://www.selleckchem.com/pr....oducts/bevacizumab.h
Metformin reduced the expression of virulence encoding genes and inhibited bacterial virulence in vitro but did not show in vivo protection. Sitagliptin significantly inhibited virulence factors in vitro, reduced the expression of virulence factors and protected mice from S. marcescens. Docking study revealed that sitagliptin is more active than metformin and fully binds to SmaR receptor, whereas vildagliptin had single interaction to SmaR. The downregulation of virulence genes was not enough to show anti-virulence activities. Hinde
Like
Comment
Share
